Biotech Moves Smarter: IDDI Powers Data-Driven Drug Innovation

 

As biotech innovation accelerates, small and mid-size pharmaceutical companies are becoming key players in bringing new treatments to market. Yet many of these organizations face steep challenges when navigating clinical trial design, regulatory approval, and data integrity. According to a McKinsey Global Institute report, industries like biotech could help generate up to $50 trillion in global revenue by 2040, underscoring their massive economic and social impact.

So how can niche research partners like IDDI help smaller biotech companies overcome these hurdles and compete in a market dominated by major pharmaceutical brands?

In this episode of While You Were Working, host Chip Rosales, Managing Partner at Rogue Marketing, speaks with Jeremy Edwards, Chief Commercial Officer at IDDI. The conversation explores how Edwards is helping IDDI expand its U.S. footprint, how the company differentiates itself in a saturated CRO market, and what innovations like AI and creative trial design mean for the future of clinical research.

Key Highlights from the Conversation:

  • Supporting Small Biotech Companies: IDDI specializes in providing hands-on, personalized trial design and data support for small and mid-size biotech firms, helping them avoid getting lost among larger CRO priorities.

  • Creative Statistical Methods & Innovation: With its spin-off “One to Treat,” IDDI is pioneering multi-endpoint trial design to capture richer, more patient-centered outcomes in areas like oncology and rare diseases.

  • Market Expansion & Differentiation: Edwards’ top priorities include building U.S. brand awareness, leveraging therapeutic area expertise, and introducing differentiated messaging in a traditionally conservative industry.

Jeremy Edwards is a seasoned executive in clinical research and digital health, with over two decades of experience leading commercial strategy, business development, and international expansion for CROs and biotech service organizations. He currently serves as Chief Commercial Officer at IDDI, where he focuses on clinical trial design innovation and expanding the company’s U.S. presence. Previously, Edwards held senior leadership roles at YPrime, Xperiome, and AMRA Medical, consistently driving growth through strategic partnerships, rare disease expertise, and technology-enabled patient engagement.

Recent Episodes

In this episode of the SparkCast, Aby Varma—founder of Spark Novus, a firm that helps marketing leaders adopt AI responsibly and strategically—sits down with Daniel Kravtsov, CEO and Co-Founder of Improvado. Daniel shares his unique journey from Russia to founding a cutting-edge martech company in the Bay Area. Together, they explore how AI agents…

At SchraubTec 2025 in Hanover, Germany, Apex Tool Group showcased its latest solutions at the intersection of precision and performance. This industry-leading event brought together innovators and manufacturers pushing the limits of smart assembly. With Apex’s presence, the spotlight was firmly on engineering excellence and future-ready tool technology.

In the world of industrial manufacturing, the real breakthrough often comes not from the tool itself, but from the moment a frustrated process finds its fix. For customers struggling with inefficiencies, injuries, or inadequate support, the right solution can feel like a long shot—until someone shows up with the right insight and product lineup….